First Interstate BancSystem heads into its April 30 Q1 print with short sellers meaningfully more active than a month ago — and options traders joining them on the defensive side.
Short interest is the headline story here. At 8.8% of free float, the short position is not extreme in absolute terms, but the pace of change is striking. Shorts jumped roughly 15% in a single week, adding to a 12% build over the prior month. The ORTEX short score of 62.6 ranks in the 2nd percentile of the universe — a signal that bearish pressure on this name is elevated relative to most peers. What makes the setup unusual is the disconnect with borrow conditions: cost to borrow remains negligible at 0.54%, and the lending pool is still comfortably available, meaning the short build reflects deliberate conviction rather than a forced or crowded squeeze dynamic.
Options positioning reinforces that caution. The put/call ratio jumped to 0.41 on the eve of the print — more than three standard deviations above its 20-day average of 0.22. That's a sharp repricing of downside protection in a single session. The move against recent history is notable: for most of the past month, the PCR barely registered demand for puts. That it doubled in one day, and on earnings eve specifically, adds weight to the signal.
The analyst debate captures the tension well. Bulls point to a consistent track record of beating estimates — the EPS surprise factor scores in the 97th percentile — and argue that CEO Kevin Reuter's focus on cost control and credit quality supports further earnings growth. Bears, led most visibly by UBS's April 7 downgrade to Sell with a $30 target, flag softer loan growth, rising nonperforming assets, and branch network restructuring costs weighing on NII. Keefe, Bruyette & Woods maintained its Outperform but trimmed its target to $38 two days later, while Piper Sandler cut from $44 to $41 in early April — a pattern of still-positive ratings paired with shrinking upside. The mean price target of $36.38 sits modestly above the current $34.43, implying limited consensus cushion if the print disappoints.
Institutional flows add one further wrinkle. BlackRock added over 6 million shares in Q1 — a substantial 6.2M share increase to a 14.0% stake — while James Scott, listed among the top holders, trimmed by 510,000 shares in late March. On the insider side, the CEO and CFO both registered small open-market sales in mid-March at prices just below current levels. None of the individual insider trades are large enough to move the needle alone, but the direction is uniformly toward the exit.
The print is therefore less a test of whether FIBK can beat a modest bar — its EPS surprise history suggests it likely can — and more a question of whether management's NII trajectory and credit quality commentary can justify the recent recovery from April lows against a backdrop where professional positioning has turned markedly more defensive.
See the live data behind this article on ORTEX.
Open FIBK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
